PD-Rx Pharmaceuticals product recalled over manufacturing violations
- Recall date
- January 25, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- PD-Rx Pharmaceuticals, Inc. recalls PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC 55289-673…
- Recall number
- D-0341-2018
- FDA classification
- Class II
- Brand / firm
- PD-Rx Pharmaceuticals, Inc.
- Sold / distributed
- Nationwide
Why it was recalled
CGMP deviations.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC 55289-673-30; c) 50 tablets NDC 55289-673-50; d) 60 tablets NDC 55289-673-60
Get recall alerts
Free email alert whenever PD-Rx Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: PD-Rx Pharmaceuticals, Inc.